H-score and ERBB2 mRNA refine identification of HER2-low and HER2-ultralow breast cancer. Sartori GP, Ramalho S, da Silva LR, Telles GD, et al. Breast Cancer Res 2026 Jul 8. doi: 10.1186/s13058-026-02334.

Read + Share

Amedeo Smart

Independent Medical Education

Sartori GP, Ramalho S, da Silva LR, Telles GD, et al. H-score and ERBB2 mRNA refine identification of HER2-low and HER2-ultralow breast cancer. Breast Cancer Res 2026 Jul 8. doi: 10.1186/s13058-026-02334.
PMID: 42421039